MedPath

The Effect of Tele-Nursing Based Motivational Interviewing in Individuals With Type 2 Diabetes:RCT

Not Applicable
Completed
Conditions
Motivational Interview
Cholesterol; Lipidosis
LDL - Low Density Lipoprotein Receptor Disorder
Type2 Diabetes
Self Efficacy
Self Management
Tele-nursing
High Density Lipoprotein Deficiency
Interventions
Behavioral: Tele-Nursing based Motivational Interviewing
Registration Number
NCT05628259
Lead Sponsor
Pamukkale University
Brief Summary

This study carried out to examine the effect of tele-nursing based motivational interviewing on diabetes self-efficacy, diabetes self-management and metabolic control parameters (Body mass index, waist circumference, HbA1c%,fasting blood glucose, LDL cholesterol, HDL cholesterol, total cholesterol, triglyceride) in individuals with type 2 diabetes.

Detailed Description

The first researcher of the article who applied Motivational Interviewing Techniques has a "Motivational Interviewing Techniques Training" certificate. A motivational interview (MI) program based on the telenursing approach was prepared by the researchers based on the literature for the individuals in the experimental group. In this study, the MI procedure includes eight sessions in total, with four sessions of motivational interviews by phone in the first month of the intervention and four sessions of motivational interviews by phone in the next two months for each individual. Pre-tests were collected in the first month. Afterwards, MI intervention was applied for three months. This intervention was applied to the experimental group in addition to the routine care provided by the hospital. MI application took an average of 45-60 minutes via phone call.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  1. being over 18 years old, 2) receiving insulin or insulin + oral therapy, 3) diagnosis of type 2 diabetes at least one year ago, 4) having a BMI of 25 and above, 5) HbA1c value of 7 and above, 6) access to phone, 7) voluntarily agreeing to participate in the study.
Exclusion Criteria
  1. have a physical disability.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupTele-Nursing based Motivational InterviewingA motivational interview (MI) program based on the telenursing approach was applied to the individuals in the experimental group. In this study, the MI procedure includes eight sessions in total, with four sessions of motivational interviews by phone in the first month of the intervention and four sessions of motivational interviews by phone in the next two months for each individual. Pre-tests were collected in the first month. Afterwards, MI intervention was applied for three months. This intervention was applied to the experimental group in addition to the routine care provided by the hospital. MI application took an average of 45-60 minutes via phone call.
Primary Outcome Measures
NameTimeMethod
Diabetes Self-Management ScaleChange from Baseline diabetes self-management at 6 months

This scale was used to measure the behavioral component of individuals in the IMB model. The validity and reliability study of the Turkish Diabetes Self-Management Perception Scale was conducted by Eroğlu and Sabuncu (2018). The scale consists of 16 items and 4 sub-dimensions and is a 4-point Likert type. Glucose Management sub-dimension: Items 4, 6, 10, 12 (items 4 and 12 are about drug use, items 1, 6 and 10 are about blood glucose monitoring). Diet Control sub-dimension: Items 2, 5, 9, 13. Physical Activity sub-dimension: Items 8, 11, 15. Use of Health Services sub-dimension: It consists of 3, 7, 14, and 16 items. The DMS scale consists of 16 items, 7 of which are straight and 9 of which are reversed. The scores of the items numbered "5, 7, 10, 11, 12, 13, 14, 15 and 16" in the scale are calculated by reversing them. Diabetes self-management increases as the score gets closer to 10.

Diabetes Self-Efficacy ScaleChange from Baseline diabetes self-efficacy at 6 months

The change in diabetes self efficacy of individuals with Type 2 diabetes at 3rd month and 6 rd month with the Diabetes Self-Efficacy Scale.

Secondary Outcome Measures
NameTimeMethod
HbA1c%Change from Baseline HbA1c% at 6 months

Hemoglobin A1C

TriglycerideChange from Baseline total triglyceride at 6 months

triglyceride

BMIChange from Baseline Body Mass Index at 6 months

Body Mass Index

HDLChange from Baseline HDL at 6 months

High-density lipoprotein

waist circumferenceChange from Baseline waist circumference at 6 months

waist circumference

LDLChange from Baseline LDL at 6 months

Low-density lipoprotein

Total cholesterolChange from Baseline total cholesterol at 6 months

Total cholesterol

FBGChange from Baseline Fasting glucose at 6 months

Fasting blood glucose

Trial Locations

Locations (3)

Şengül AYDIN YOLDEMİR

🇹🇷

Istanbul, Turkey

Eda Kılınç İşleyen

🇹🇷

Pamukkale, Denizli, Turkey

İrem Nur ÖZDEMİR

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath